Aurinia Announces Results of the 2021 Annual General Meeting

Rhea-AI Summary

Aurinia Pharmaceuticals announced that all eight incumbent directors were re-elected during the annual general meeting held on June 7, 2021. The voting results showed a strong endorsement, with Peter Greenleaf receiving the highest approval at 92.18%. The Company also confirmed that all other matters voted on were approved. For detailed voting results, stakeholders can refer to the filings on SEDAR and EDGAR.

Positive

• All eight incumbent directors were re-elected, indicating strong shareholder support.
• Voting results for all matters at the meeting were approved.

Negative

• None.

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (“Aurinia” or the “Company”) is pleased to announce that the eight incumbent directors of the Company were elected at the Company’s annual general meeting (the “Meeting”) held on June 7, 2021.

Detailed results of the vote by proxy for the election of directors are provided below:

Nominee				Votes For (%)				Votes Withheld (%)
George M. Milne				80.91				19.09
Peter Greenleaf				92.18				7.82
David R.W. Jayne				93.00				7.00
Joseph P. Hagan				87.15				12.85
Daniel G. Billen				95.64				4.36
R. Hector MacKay-Dunn				93.27				6.73
Jill Leversage				95.05				4.95
Timothy P. Walbert				89.56				10.44

In addition, following final tallies of votes, all other matters voted on at the Meeting were also approved. Voting results on all matters voted on at the Meeting will be filed on SEDAR at www.sedar.com and EDGAR at www.edgar.com.

About Aurinia

Aurinia Pharmaceuticals is a fully integrated biopharmaceutical company focused on delivering therapies to treat targeted patient populations that are impacted by serious diseases with a high unmet medical need. The Company’s head office is in Victoria, British Columbia, its U.S. commercial hub is in Rockville, Maryland, and the Company focuses its development efforts globally.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210607005782/en/

FAQ

What was the date of Aurinia's annual general meeting in 2021?

The annual general meeting of Aurinia Pharmaceuticals was held on June 7, 2021.

What percentage of votes did Peter Greenleaf receive in the election?

Peter Greenleaf received 92.18% of the votes in the election.

Where can I find detailed voting results for Aurinia's annual meeting?

Detailed voting results can be found on SEDAR and EDGAR.

What matters were voted on during Aurinia's annual general meeting?

All matters voted on during the meeting were approved.